These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16873289)

  • 1. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
    O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
    Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
    Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.
    Boidot R; Vegran F; Lizard-Nacol S
    Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
    Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
    Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
    Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
    Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
    Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
    Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
    Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
    Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
    Végran F; Boidot R; Bonnetain F; Cadouot M; Chevrier S; Lizard-Nacol S
    Endocr Relat Cancer; 2011 Dec; 18(6):783-92. PubMed ID: 21878572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
    Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
    Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
    Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
    J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.
    Pavlidou A; Kroupis C; Goutas N; Dalamaga M; Dimas K
    Clin Breast Cancer; 2014 Apr; 14(2):122-31. PubMed ID: 24325949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.